OAC
LEGN icon

OMERS Administration Corp’s Legend Biotech LEGN Stock Holding History

OMERS Administration Corp’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$266K Buy
+9,200
New +$248K ﹤0.01% 849
2025
Q2 		– Sell
-40,400
Closed -$1.37M – 1007
2025
Q1 		$1.37M Buy
+40,400
New +$1.45M 0.01% 496

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

OMERS Administration Corp's LEGN Position: Q2 2026 in Review

OMERS Administration Corp opened a new position in Legend Biotech (LEGN) in Q2 2026: 9,200 shares worth $266K. The stake represents ﹤0.01% of the portfolio and ranks #849 among its holdings. This is a return to the name: OMERS Administration Corp previously reported a position in LEGN as recently as Q1 2025.

OMERS Administration Corp first reported a position in LEGN in Q1 2025 and has held it in 2 quarters since. The position peaked at $1.37M in Q1 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • OMERS Administration Corp held 9,200 shares of Legend Biotech worth $266K as of Q2 2026.
  • Legend Biotech was a new OMERS Administration Corp position in Q2 2026.
  • Legend Biotech made up ﹤0.01% of OMERS Administration Corp's portfolio in Q2 2026, its #849 holding.
  • OMERS Administration Corp first reported a position in Legend Biotech in Q1 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's Legend Biotech position peaked at $1.37M in Q1 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.